SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
Theravance Biopharma, Inc.
@TBPH_InsiderForm 4 Filing: Farnum Rhonda Sells $218,167.201 of $TBPH
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Theravance Biopharma, Inc.
Ticker: $TBPH
Transaction Value
$218,167.201
Price/Share: $16.39
transaction date
2026-06-15
Shares: 13,314
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Farnum Rhonda, holds the title of SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc..
On 2026-06-15, the insider transacted 13,314 shares.The shares were transacted at a weighted average price of $16.39 per share, resulting in a total market-relevant value of $218,167.201.
Executive Summary Summary
Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) sold $218K of $TBPH
Post-Transaction Position: 232,457 shares
SEC Accession No: 0001898490-26-000010 (CIK: 1898490)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.